Investigating immunotherapies for endometrial cancer: Working as a MDT to identify patients and improve outcomes - Part 1

from touchPODCAST · host touchpodcast

touchMDT for touchONCOLOGY Listen to key experts from a multidisciplinary team discuss the latest data on PD-1/PD-L1 inhibitors and what they mean for patients with EC. The multidisciplinary team Gynaecological oncologist: Prof. Nicole Concin Medical oncologist: Dr Antonio González-Martín This touchPODCAST is for HCPs only. This activity is funded by an unrestricted independent medical education grant from GlaxoSmithKline. This activity is provided by touchIME. For further information visit our website: https://touchoncology.com/education/mdt-for-io-in-ec/

Episode metadata supplied by the publisher feed · Published Sep 23, 2021

Embed this episode

Attribution link and audio player

Ready to play

Investigating immunotherapies for endometrial cancer: Working as a MDT to identify patients and improve outcomes - Part 1

0:00 13:18

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

No similar podcasts found.

Frequently Asked Questions

How long is this episode of touchPODCAST?

This episode is 13 minutes long.

When was this touchPODCAST episode published?

This episode was published on September 23, 2021.

Can I download this touchPODCAST episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!